[Retropharyngeal phlegmon caused by a group B Streptococcus in a diabetic patient: report of one case].
We report a 47 year-old diabetic male, admitted due to metabolic decompensation, malaise, purulent pharyngeal discharge and a mass in the posterior cervical region. Blood glucose was 270 mg/dl, a nasopharyngoscopy showed a pharyngeal phlegmon and CT scan confirmed the presence of a phlegmon in the retropharyngeal region. He was treated with sodium penicillin, cloxacillin and ceftriazone and the phlegmon was drained surgically. The culture of the purulent discharge gave growth to a Group B Streptococcus. The evolution was favorable and the patient completed seven days with intravenous antimicrobials and additional seven days with oral ampicillin/sulbactam.
Sapunar Z
Jorge
J
Unidad de Endocrinología y Diabetes, Departamento de Medicina Interna, Facultad de Medicina, Universidad de La Frontera, Santiago, Chile. jsapunar@ufro.cl
Cabello V
Alvaro
A
Godoy R
Emilio
E
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy / Q000382:microbiology*; D003023:Cloxacillin / Q000627:therapeutic use; D048909:Diabetes Complications / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009333:Neck; D017703:Retropharyngeal Abscess / Q000188:drug therapy / Q000382:microbiology*; D013290:Streptococcal Infections / Q000150:complications* / Q000188:drug therapy; D013292:Streptococcus agalactiae / Q000187:drug effects / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D003023:Cloxacillin